Search
User Avatar Login
The Defender
  • Explore The Defender
  • Categories
    • CHD.TV
  • Explore CHD.TV
  • Archive
    • Resources
  • Explore Our Resources
  • CHD Bookstore
  • CHD Films
  • eBooks
    • Community
  • Explore Advocacy
  • Community
  • Advocacy Help
    • Science
  • Explore the Science Section
  • Science Library
  • Vaccines
  • Electromagnetic Radiation
    • Legal Justice
  • Explore Litigation
  • Learn The Law
    • About Us
  • About Children’s Health Defense
  • More from CHD
    • Vax-Unvax: Let The Science Speak Home › Citations

    Chapter 3

    This is a listing of all citations in this chapter.

    31

    David A. Geier et al., “Thimerosal Exposure and Disturbance of Emotions Specific to Childhood and Adolescence: A Case-Control Study in the Vaccine Safety Datalink (VSD) Database,” Brain Injury 31, no. 2 (2017): 272-278. doi:10.1080/02699052.2016.1250950.

    32

    David A. Geier, Janet K. Kern and Mark R. Geier, “Premature Puberty and Thimerosal-Containing Hepatitis B Vaccination: A Case-Control Study in the Vaccine Safety Datalink,” Toxics 6, no. 4 (2018): 67, doi:10.3390/toxics6040067.

    33

    David A. Geier et al., “Thimerosal: Clinical, Epidemiologic and Biochemical Studies,” Clinica Chimica Acta, 444 (2015): 212-20, doi:10.1016/j.cca.2015.02.030.

    34

    Put Children First, “Thimerosal Timeline,” accessed on September 19, 2022.

    35

    Heather A. Young, David A. Geier and Mark R. Geier, “Thimerosal Exposure in Infants and Neurodevelopmental Disorders: An Assessment of Computerized Medical Records in the Vaccine Safety Datalink,” Journal of the Neurological Sciences 271, no. 1-2 (2008): 110-118. doi:10.1016/j.jns.2008.04.002.

    36

    Heather A. Young, David A. Geier and Mark R. Geier, “Thimerosal Exposure in Infants and Neurodevelopmental Disorders: An Assessment of Computerized Medical Records in the Vaccine Safety Datalink,” Journal of the Neurological Sciences 271, no. 1-2 (2008): 110-118. doi:10.1016/j.jns.2008.04.002.

    37

    David A. Geier et al., “A Two-Phase Study Evaluating the Relationship Between Thimerosal-Containing Vaccine Administration and the Risk for an Autism Spectrum Disorder Diagnosis in the United States,” Translational Neurodegeneration 2, no. 1 (2013): 25, doi:10.1186/2047-9158-2-25.

    38

    David A. Geier et al., “A Two-Phase Study Evaluating the Relationship Between Thimerosal-Containing Vaccine Administration and the Risk for an Autism Spectrum Disorder Diagnosis in the United States,” Translational Neurodegeneration 2, no. 1 (2013): 25, doi:10.1186/2047-9158-2-25.

    39

    David A. Geier et al., “A Two-Phase Study Evaluating the Relationship Between Thimerosal-Containing Vaccine Administration and the Risk for an Autism Spectrum Disorder Diagnosis in the United States,” Translational Neurodegeneration 2, no. 1 (2013): 25, doi:10.1186/2047-9158-2-25.

    40

    David A. Geier et al., “A Two-Phase Study Evaluating the Relationship Between Thimerosal-Containing Vaccine Administration and the Risk for an Autism Spectrum Disorder Diagnosis in the United States,” Translational Neurodegeneration 2, no. 1 (2013): 25, doi:10.1186/2047-9158-2-25.

    41

    David A. Geier et al., “A Two-Phase Study Evaluating the Relationship Between Thimerosal-Containing Vaccine Administration and the Risk for an Autism Spectrum Disorder Diagnosis in the United States,” Translational Neurodegeneration 2, no. 1 (2013): 25, doi:10.1186/2047-9158-2-25.

    42

    David A. Geier et al., “Thimerosal-Containing Hepatitis B Vaccination and the Risk for Diagnosed Specific Delays in Development in the United States: A Case-Control Study in the Vaccine Safety Datalink,” North American Journal of Medical Sciences 6, no. 10 (2014): 519-531, doi:10.4103/1947-2714.143284.

    43

    David A. Geier et al., “Thimerosal Exposure and Increased Risk for Diagnosed Tic Disorder in the United States: A Case-Control Study,” Interdisciplinary Toxicology 8, no. 2 (2015): 68-76, doi: 10.1515/intox-2015-0011.

    44

    David A. Geier et al., “Thimerosal-Containing Hepatitis B Vaccination and the Risk for Diagnosed Specific Delays in Development in the United States: A Case-Control Study in the Vaccine Safety Datalink,” North American Journal of Medical Sciences 6, no. 10 (2014): 519-531, doi:10.4103/1947-2714.143284.

    45

    David A. Geier et al., “Thimerosal Exposure and Increased Risk for Diagnosed Tic Disorder in the United States: A Case-Control Study,” Interdisciplinary Toxicology 8, no. 2 (2015): 68-76, doi:10.1515/intox-2015-0011.

    46

    David A. Geier et al., “Thimerosal-Containing Hepatitis B Vaccination and the Risk for Diagnosed Specific Delays in Development in the United States: A Case-Control Study in the Vaccine Safety Datalink,” North American Journal of Medical Sciences 6, no. 10 (2014): 519-531, doi:10.4103/1947-2714.143284.

    47

    David A. Geier et al., “Thimerosal Exposure and Increased Risk for Diagnosed Tic Disorder in the United States: A Case-Control Study,” Interdisciplinary Toxicology 8, no. 2 (2015): 68-76, doi:10.1515/intox-2015-0011.

    48

    David A. Geier et al., “Thimerosal Exposure and Increased Risk for Diagnosed Tic Disorder in the United States: A Case-Control Study,” Interdisciplinary Toxicology 8, no. 2 (2015): 68-76, doi:10.1515/intox-2015-0011.

    49

    David A. Geier et al., “Thimerosal-Containing Hepatitis B Vaccination and the Risk for Diagnosed Specific Delays in Development in the United States: A Case-Control Study in the Vaccine Safety Datalink,” North American Journal of Medical Sciences 6, no. 10 (2014): 519-531, doi:10.4103/1947-2714.143284.

    50

    David A. Geier et al., “Thimerosal Exposure and Disturbance of Emotions Specific to Childhood and Adolescence: A Case-Control Study in the Vaccine Safety Datalink (VSD) Database,” Brain Injury 31, no. 2 (2017): 272-278. doi:10.1080/02699052.2016.1250950.

    51

    David A. Geier, Janet K. Kern and Mark R. Geier, “Premature Puberty and Thimerosal-Containing Hepatitis B Vaccination: A Case-Control Study in the Vaccine Safety Datalink,” Toxics 6, no. 4 (2018): 67, doi:10.3390/toxics6040067.

    52

    David A. Geier et al., “Thimerosal Exposure and Disturbance of Emotions Specific to Childhood and Adolescence: A Case-Control Study in the Vaccine Safety Datalink (VSD) Database,” Brain Injury 31, no. 2 (2017): 272-278. doi:10.1080/02699052.2016.1250950.

    53

    David A. Geier, Janet K. Kern and Mark R. Geier, “Premature Puberty and Thimerosal-Containing Hepatitis B Vaccination: A Case-Control Study in the Vaccine Safety Datalink,” Toxics 6, no. 4 (2018): 67, doi:10.3390/toxics6040067.

    54

    David A. Geier, Janet K. Kern and Mark R. Geier, “Premature Puberty and Thimerosal-Containing Hepatitis B Vaccination: A Case-Control Study in the Vaccine Safety Datalink,” Toxics 6, no. 4 (2018): 67, doi:10.3390/toxics6040067.

    55

    David A. Geier, Janet K. Kern and Mark R. Geier, “Premature Puberty and Thimerosal-Containing Hepatitis B Vaccination: A Case-Control Study in the Vaccine Safety Datalink,” Toxics 6, no. 4 (2018): 67, doi:10.3390/toxics6040067.

    56

    David A. Geier et al., “Thimerosal Exposure and Disturbance of Emotions Specific to Childhood and Adolescence: A Case-Control Study in the Vaccine Safety Datalink (VSD) Database,” Brain Injury 31, no. 2 (2017): 272-278. doi:10.1080/02699052.2016.1250950.

    57

    Paul E. M. Fine and Robert T. Chen, “Confounding in Studies of Adverse Reactions to Vaccines,” American Journal of Epidemiology 136, no. 2 (1992): 121-135, doi:10.1093/oxfordjournals.aje.a116479.

    58

    David A. Geier et al., “Thimerosal-Containing Hepatitis B Vaccination and the Risk for Diagnosed Specific Delays in Development in the United States: A Case-Control Study in the Vaccine Safety Datalink,” North American Journal of Medical Sciences 6, no. 10 (2014): 519-531, doi:10.4103/1947-2714.143284.

    59

    Carolyn M. Gallagher and Melody S. Goodman. “Hepatitis B Vaccination of Male Neonates and Autism Diagnosis, NHIS 1997-2002,” Journal of Toxicology and Environmental Health Part A 73, no. 24 (2010): 1665-167, doi:10.1080/15287394.2010.519317.

    60

    Carolyn M. Gallagher and Melody S. Goodman. “Hepatitis B Vaccination of Male Neonates and Autism Diagnosis, NHIS 1997-2002,” Journal of Toxicology and Environmental Health Part A 73, no. 24 (2010): 1665-167, doi:10.1080/15287394.2010.519317.